Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Non Operating Income: 2018-2024

Historic Non Operating Income for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to $1.9 million.

  • Pharming Group N.V's Non Operating Income rose 49.68% to -$3.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$14.1 million, marking a year-over-year decrease of 3020.54%. This contributed to the annual value of $1.9 million for FY2024, which is 129.81% up from last year.
  • Latest data reveals that Pharming Group N.V reported Non Operating Income of $1.9 million as of FY2024, which was up 129.81% from -$6.3 million recorded in FY2023.
  • Pharming Group N.V's 5-year Non Operating Income high stood at $8.8 million for FY2021, and its period low was -$32.5 million during FY2020.
  • For the 3-year period, Pharming Group N.V's Non Operating Income averaged around -$2.2 million, with its median value being -$2.2 million (2022).
  • In the last 5 years, Pharming Group N.V's Non Operating Income tumbled by 192.93% in 2023 and then skyrocketed by 129.81% in 2024.
  • Yearly analysis of 5 years shows Pharming Group N.V's Non Operating Income stood at -$32.5 million in 2020, then skyrocketed by 127.13% to $8.8 million in 2021, then tumbled by 124.52% to -$2.2 million in 2022, then plummeted by 192.93% to -$6.3 million in 2023, then skyrocketed by 129.81% to $1.9 million in 2024.